Dr. Eric Kleinbaum, M.D.
What this data tells you about Dr. Kleinbaum
Dr. Eric Kleinbaum is a hematology & oncology in Houston, TX, with 19 years in practice. Based on federal Medicare data, Dr. Kleinbaum performed 114,931 Medicare services across 1,784 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kleinbaum received a total of $6,138 from 60 pharmaceutical and/or device companies across 331 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kleinbaum is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 72,000 | $1 | $3 |
| Contrast dye for imaging (iodine-based) | 17,900 | $0 | $0 |
| Anti-nausea injection (fosaprepitant) | 9,750 | $0 | $1 |
| MRI contrast dye injection (gadoterate) | 7,250 | $0 | $0 |
| Dexamethasone injection (steroid) | 2,174 | $0 | $0 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,240 | $1 | $5 |
| Office visit, established patient (30-39 min) | 1,124 | $91 | $346 |
| Flow cytometry, additional marker | 625 | $19 | $63 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 607 | $22 | $82 |
| Administration of chemotherapy into vein, 1 hour or less | 331 | $96 | $375 |
| Office visit, established patient (20-29 min) | 311 | $62 | $245 |
| Drug injection, under skin or into muscle | 161 | $10 | $38 |
| Administration of chemotherapy into vein, each additional hour | 156 | $21 | $80 |
| Ct scan of chest with contrast | 143 | $54 | $428 |
| Administration of additional new drug or substance into vein, 1 hour or less | 129 | $49 | $183 |
| CT scan of abdomen and pelvis with contrast | 126 | $163 | $812 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 119 | $46 | $179 |
| New patient office visit (45-59 min) | 106 | $116 | $452 |
| Irrigation of implanted venous access drug delivery device | 85 | $18 | $73 |
| Injection, diphenhydramine hcl, up to 50 mg | 68 | $1 | $3 |
| Hospital follow-up visit, moderate complexity | 65 | $56 | $200 |
| Infusion into a vein for hydration, each additional hour | 57 | $10 | $36 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 47 | $1,132 | $5,457 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 43 | $109 | $295 |
| Ct scan of soft tissue of neck with contrast | 38 | $59 | $443 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 36 | $17 | $62 |
| Complete ultrasound scan of abdomen | 35 | $54 | $278 |
| Hospital follow-up visit, high complexity | 33 | $89 | $297 |
| Mri scan of brain before and after contrast | 26 | $138 | $863 |
| Flow cytometry technique for dna or cell analysis, first marker | 25 | $60 | $194 |
| CT scan of chest, without contrast | 22 | $34 | $335 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 21 | $133 | $479 |
| Office visit, established patient (10-19 min) | 18 | $43 | $156 |
| Ct scan of abdomen and pelvis without contrast | 17 | $62 | $467 |
| Mri scan of abdomen before and after contrast | 17 | $191 | $915 |
| Initial hospital admission, moderate complexity | 14 | $100 | $355 |
| New patient office visit (30-44 min) | 12 | $59 | $300 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kleinbaum is a mixed practice specialist, with above-average Medicare volume (top 5% in TX), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kleinbaum experienced with iron infusion (injectafer)?
Does Dr. Kleinbaum receive payments from pharmaceutical companies?
How do Dr. Kleinbaum's costs compare to other hematology & oncologys in Houston?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology